GO:0003308 negative regulation of Wnt signaling pathway involved in heart development: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003308 describes the biological process that decreases the rate, frequency, or extent of Wnt signaling specifically during heart development.
• Negative regulation of Wnt signaling is essential for proper cardiac differentiation, chamber formation, and outflow tract development.
• Key negative regulators include Axin2, Nkd1, Dickkopf-3 (DKK3), and Pr72, which act at different levels of the Wnt cascade.
• Dysregulation of this process is linked to myocardial infarction, atherosclerosis, and cardiac developmental defects.
• CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the causal roles of negative regulators in heart development.
• Understanding GO:0003308 provides insights into congenital heart disease and potential therapeutic targets for cardiac repair.
Description
The Gene Ontology term GO:0003308, negative regulation of Wnt signaling pathway involved in heart development, defines any process that decreases the rate, frequency, or extent of the series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell, resulting in a change in cell state that contributes to the progression of the heart over time. This process is critical because Wnt signaling must be tightly controlled during cardiogenesis; excessive or prolonged Wnt activity can impair cardiac differentiation and lead to structural heart defects. Researchers study this term to understand how negative regulators such as Axin2 and Nkd1 fine-tune Wnt output in cardiac progenitors. Dysregulation of negative regulation of Wnt signaling in the heart has been implicated in human pathologies ranging from myocardial infarction to atherosclerosis. For example, miR-30b-5p promotes myocardial cell apoptosis by modulating Wnt/β-catenin signaling, highlighting the importance of negative regulatory mechanisms in cardiac injury. Similarly, ablation of Dickkopf-3, a secreted Wnt antagonist, attenuates atherosclerosis in ApoE-deficient mice, linking this GO term to vascular biology. These findings underscore why precise experimental models are needed to dissect the molecular players involved. This article provides a research-grade overview of GO:0003308, covering its definition, key genes, regulatory mechanisms, disease associations, and state-of-the-art methods including CRISPR-based models. All statements are grounded in published literature to support reproducibility and generative-AI retrieval.
negative regulation of Wnt signaling pathway involved in heart development At A Glance
| GO ID | GO:0003308 |
|---|---|
| GO term | negative regulation of Wnt signaling pathway involved in heart development |
| Ontology | biological_process |
| Synonym | negative regulation of Wnt-activated signaling pathway involved in heart development; negative regulation of Wnt receptor signaling pathway involved in heart development; negative regulation of Wnt receptor signalling pathway involved in heart development |
| Major function | Attenuation of Wnt/β-catenin signaling during cardiac differentiation, chamber formation, and outflow tract development |
| Key regulators | Axin2, Nkd1, DKK3, Pr72, miR-30b-5p |
| Associated diseases | Myocardial infarction, atherosclerosis, congenital heart defects |
| Research methods | CRISPR knockout/knock-in, RNA-seq, reporter assays, zebrafish models |
What Is GO:0003308?
GO:0003308 is a biological process term that encompasses any molecular event or pathway that reduces the intensity, duration, or spatial extent of Wnt signaling specifically in the context of heart development. It includes mechanisms such as sequestration of Wnt ligands, degradation of β-catenin, inhibition of Wnt receptor activation, and transcriptional repression of Wnt target genes, all of which contribute to proper cardiac morphogenesis and function.
Why Is negative regulation of Wnt signaling pathway involved in heart development Important in Cell Biology?
GO:0003308 is important because precise temporal and spatial control of Wnt signaling is a prerequisite for normal heart development. Negative regulators act as brakes that prevent excessive Wnt activity, which would otherwise disrupt cardiac progenitor differentiation and lead to malformations. Moreover, reactivation of Wnt signaling is observed in cardiac injury and disease, making these negative regulators potential therapeutic targets. Understanding this process at the molecular level can inform strategies for regenerative medicine and congenital heart disease intervention.
• Ensures proper cardiac differentiation from mesodermal progenitors by limiting Wnt/β-catenin activity.
• Controls outflow tract and chamber morphogenesis during embryogenesis.
• Prevents pathological cardiac hypertrophy and apoptosis after myocardial infarction.
• Modulates vascular homeostasis and atherosclerosis progression.
• Influences cardiomyocyte proliferation and regenerative capacity.
• Provides mechanistic insights into congenital heart defects linked to Wnt dysregulation.
• Serves as a paradigm for understanding context-dependent Wnt signaling in other organs.
• Offers targets for pharmacological modulation of Wnt in cardiac disease.
• Enables CRISPR-based functional genomics of heart development.
• Connects to broader signaling networks including AKT and ROS in cardiomyocyte differentiation.
What Happens During negative regulation of Wnt signaling pathway involved in heart development?
Sequestration and Degradation of β-Catenin
In simple terms: The cell destroys the key messenger of Wnt signaling to keep the pathway off.
In the absence of Wnt, a destruction complex containing Axin2, APC, and GSK3β phosphorylates β-catenin, targeting it for ubiquitination and proteasomal degradation. Axin2 itself is a transcriptional target of Wnt, creating a negative feedback loop that attenuates signaling. Nkd1 functions downstream of Axin2 to further attenuate Wnt signaling, as shown in Mol Biol Cell. This degradation ensures that β-catenin levels remain low in cardiac progenitors, preventing premature or excessive Wnt target gene activation.
Inhibition of Wnt Receptor Complex
In simple terms: Decoy molecules block the Wnt signal from reaching the cell surface receptors.
Secreted antagonists such as Dickkopf-3 (DKK3) bind to LRP5/6 co-receptors and prevent Wnt-Frizzled complex formation. Ablation of DKK3 attenuates atherosclerosis in ApoE-deficient mice, demonstrating its role in vascular and cardiac contexts. Similarly, other secreted frizzled-related proteins can sequester Wnt ligands, reducing pathway activation during heart development.
Transcriptional Repression of Wnt Target Genes
In simple terms: The cell turns off genes that would otherwise promote Wnt signaling.
Negative regulators can recruit co-repressors to Wnt target gene promoters. For instance, Pr72, a regulatory subunit of protein phosphatase 2A, is required for normal cardiac development in zebrafish; its deletion causes cardiac developmental defects, likely through modulation of Wnt signaling. This transcriptional control adds another layer of negative regulation during heart morphogenesis.
Modulation by Non-coding RNAs
In simple terms: Small RNA molecules can dampen Wnt signaling by targeting components of the pathway.
MicroRNAs such as miR-30b-5p regulate Wnt/β-catenin signaling in myocardial cells. In rats with myocardial infarction, miR-30b-5p promotes apoptosis by modulating this pathway, indicating that non-coding RNAs can act as negative regulators of Wnt signaling in the heart. This adds a post-transcriptional layer to GO:0003308.
Integration with Other Signaling Pathways
In simple terms: Wnt signaling is not isolated; other pathways can put the brakes on it.
Monoamine oxidase A-dependent ROS formation modulates human cardiomyocyte differentiation through AKT and WNT activation, showing crosstalk between redox signaling and Wnt. Additionally, low Wnt/β-catenin signaling determines leaky vessels in the subfornical organ, affecting water homeostasis, which may have implications for cardiac function. These interactions highlight the complexity of negative regulation in heart development.
Key Genes Involved in GO:0003308 negative regulation of Wnt signaling pathway involved in heart development
The following genes and proteins are key players in the negative regulation of Wnt signaling during heart development, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Axin2 | Scaffold protein of β-catenin destruction complex; negative feedback regulator | Central to Wnt attenuation; knockout models show increased Wnt signaling |
| Nkd1 | Functions downstream of Axin2 to attenuate Wnt signaling | Modulates Wnt output in cardiac progenitors |
| DKK3 | Secreted Wnt antagonist; binds LRP5/6 | Ablation attenuates atherosclerosis; potential cardiac role |
| Pr72 | Regulatory subunit of PP2A; required for cardiac development | Deletion causes cardiac defects in zebrafish |
| miR-30b-5p | MicroRNA that modulates Wnt/β-catenin signaling | Promotes myocardial apoptosis in infarction |
| β-catenin | Transcriptional co-activator; target of negative regulation | Its degradation is a key readout of negative regulation |
| GSK3β | Kinase that phosphorylates β-catenin | Component of destruction complex |
| APC | Scaffold in destruction complex | Facilitates β-catenin degradation |
| LRP5/6 | Wnt co-receptors | Targets of DKK3 inhibition |
| Frizzled | Wnt receptors | Initiate signaling; subject to negative regulation |
| AKT | Kinase that crosstalks with Wnt | Modulates cardiomyocyte differentiation |
| MAOA | Monoamine oxidase A; produces ROS | Modulates Wnt activation in cardiomyocytes |
| Vitamin D receptor | Nuclear receptor that influences cardiac differentiation | May intersect with Wnt signaling |
| Wnt3a | Prototypical Wnt ligand | Used experimentally to activate pathway |
| Wnt8 | Wnt ligand in cardiac development | Subject to negative regulation |
| TCF/LEF | Transcription factors mediating Wnt target gene expression | Readout of pathway activity |
| DVL | Dishevelled; downstream of Frizzled | Component of Wnt signal transduction |
How Is negative regulation of Wnt signaling pathway involved in heart development Regulated?
The negative regulation of Wnt signaling in heart development is itself regulated at multiple levels. Axin2 is a direct transcriptional target of Wnt/β-catenin, forming a negative feedback loop that limits signaling duration. Nkd1 acts downstream of Axin2 to further attenuate the pathway. Post-translational modifications, such as phosphorylation by GSK3β, control β-catenin stability. Non-coding RNAs like miR-30b-5p can fine-tune pathway activity in response to stress. Additionally, crosstalk with AKT and ROS signaling modulates Wnt activity during cardiomyocyte differentiation. These regulatory layers ensure that Wnt signaling is appropriately dampened during critical windows of heart development.
negative regulation of Wnt signaling pathway involved in heart development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| miR-30b-5p | Myocardial infarction | Rat myocardial infarction model; overexpression/knockdown |
| DKK3 | Atherosclerosis | ApoE-deficient mouse; DKK3 knockout |
| Pr72 | Cardiac developmental defects | Zebrafish pr72 deletion |
| Axin2 | Wnt signaling imbalance; potential cardiac defects | Mouse Axin2 knockout |
| MAOA | Cardiomyocyte differentiation | Human iPSC-derived cardiomyocytes; MAOA inhibition |
Myocardial Infarction and Apoptosis
Dysregulation of negative regulation of Wnt signaling contributes to myocardial cell apoptosis after infarction. MiR-30b-5p promotes apoptosis in rats with myocardial infarction by modulating Wnt/β-catenin signaling, suggesting that restoring negative regulation could be protective.
Atherosclerosis
Dickkopf-3 (DKK3) ablation attenuates atherosclerosis in ApoE-deficient mice, indicating that DKK3-mediated negative regulation of Wnt signaling influences plaque development. This links GO:0003308 to vascular pathology.
Congenital Heart Defects
Deletion of Pr72 causes cardiac developmental defects in zebrafish, highlighting the importance of negative regulation for proper heart morphogenesis. Similarly, imbalances in Wnt signaling are associated with outflow tract defects and chamber malformations.
Cardiomyocyte Differentiation and Regeneration
Monoamine oxidase A-dependent ROS formation modulates human cardiomyocyte differentiation through AKT and WNT activation, suggesting that redox-dependent negative regulation of Wnt is critical for proper differentiation. This has implications for regenerative therapies.
From negative regulation of Wnt signaling pathway involved in heart development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Axin2 negatively regulate Wnt in cardiac progenitors? | Axin2 knockout mouse or hiPSC-derived cardiomyocytes |
| What is the role of Nkd1 downstream of Axin2? | Nkd1 knockout zebrafish or mouse |
| How does DKK3 ablation affect atherosclerosis? | ApoE-/- mouse with DKK3 knockout |
| Does Pr72 deletion cause cardiac defects? | Zebrafish pr72 knockout |
| Can miR-30b-5p modulation prevent apoptosis? | Rat myocardial infarction model with miR-30b-5p mimic/inhibitor |
| How does MAOA-dependent ROS affect Wnt in cardiomyocytes? | Human iPSC-derived cardiomyocytes with MAOA knockout |
How to Study the negative regulation of Wnt signaling pathway involved in heart development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Assess requirement of negative regulators |
| CRISPR knock-in | Tagged protein expression | Visualize localization and interactions |
| RNA-seq | Transcriptome changes | Identify Wnt target genes |
| Proteomics | Protein abundance and modifications | Quantify β-catenin degradation |
| Reporter assays | Wnt/β-catenin transcriptional activity | Screen for modulators |
| Zebrafish models | Cardiac morphogenesis | Study developmental defects |
| Human iPSC-derived cardiomyocytes | Cardiomyocyte differentiation and function | Model human cardiac disease |
CRISPR Knockout and Knock-in Models
CRISPR/Cas9-mediated knockout of negative regulators such as Axin2, Nkd1, or Pr72 allows researchers to assess their causal role in heart development. Knock-in of tagged versions enables visualization and interaction studies.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can quantify changes in Wnt target genes and β-catenin levels upon perturbation of negative regulators. This helps identify downstream effectors and feedback loops.
Reporter Assays and Imaging
Wnt/β-catenin reporter assays (e.g., TOPFlash) and live imaging of fluorescently tagged β-catenin provide dynamic readouts of pathway activity in cardiac cells.
Animal Models
Zebrafish and mouse models are invaluable for studying heart development in vivo. Zebrafish pr72 mutants show cardiac defects, while mouse Axin2 knockouts reveal Wnt dysregulation.
How CRISPR Can Be Used to Study GO:0003308 negative regulation of Wnt signaling pathway involved in heart development
Knockout
CRISPR knockout of Axin2 or Nkd1 in cardiac cell models can reveal their necessity for attenuating Wnt signaling. For example, Axin2 knockout leads to increased β-catenin and Wnt target gene expression.
Point Mutation
Introducing point mutations in key phosphorylation sites of β-catenin or in the Axin2 scaffold can dissect specific molecular interactions required for negative regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci of negative regulators allows real-time tracking of protein dynamics during heart development.
Overexpression
Overexpression of negative regulators such as DKK3 or Pr72 can suppress Wnt signaling and rescue developmental defects in model systems.
How EDITGENE Supports negative regulation of Wnt signaling pathway involved in heart development Research
Researchers studying negative regulation of Wnt signaling pathway involved in heart development-related genes often need to determine whether a candidate gene is causally involved in attenuating Wnt signaling, and to dissect the precise molecular mechanisms. This requires robust genetic models that can be rapidly generated and validated.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of Wnt signaling pathway involved in heart development research.
Frequently Asked Questions About negative regulation of Wnt signaling pathway involved in heart development
What is GO:0003308?
GO:0003308 is a Gene Ontology biological process term for any process that decreases the rate, frequency, or extent of Wnt signaling specifically during heart development.
What genes are involved in negative regulation of Wnt signaling in heart development?
Key genes include Axin2, Nkd1, DKK3, Pr72, and miR-30b-5p, among others.
Why is negative regulation of Wnt signaling important for the heart?
It prevents excessive Wnt activity that would otherwise impair cardiac differentiation and cause structural defects.
How does Axin2 negatively regulate Wnt signaling?
Axin2 is a scaffold in the β-catenin destruction complex and is transcriptionally induced by Wnt, forming a negative feedback loop.
What diseases are linked to dysregulation of this process?
Myocardial infarction, atherosclerosis, and congenital heart defects have been associated with altered negative regulation of Wnt signaling.
What model systems are used to study GO:0003308?
Zebrafish, mice, and human iPSC-derived cardiomyocytes are commonly used, along with CRISPR knockout and knock-in models.
How can CRISPR help study negative regulation of Wnt in heart development?
CRISPR enables knockout, point mutation, knock-in, and overexpression of candidate genes to test their causal role in Wnt attenuation.
What is the role of DKK3 in heart development?
DKK3 is a secreted Wnt antagonist; its ablation attenuates atherosclerosis in mice, suggesting a role in vascular and cardiac biology.
Does Pr72 regulate Wnt signaling in the heart?
Deletion of Pr72 causes cardiac developmental defects in zebrafish, likely through modulation of Wnt signaling.
How does miR-30b-5p affect Wnt signaling in myocardial infarction?
miR-30b-5p promotes myocardial cell apoptosis by regulating Wnt/β-catenin signaling in rats.
Conclusion
GO:0003308, negative regulation of Wnt signaling pathway involved in heart development, is a critical biological process that ensures proper cardiac morphogenesis and function. Key negative regulators such as Axin2, Nkd1, DKK3, and Pr72 act at multiple levels to dampen Wnt signaling, and their dysregulation is linked to myocardial infarction, atherosclerosis, and congenital heart defects. Understanding these mechanisms offers opportunities for therapeutic intervention and regenerative medicine. Advanced CRISPR-based models and multi-omics approaches are essential to dissect the causal roles of these regulators. EDITGENE provides comprehensive services to accelerate research in this field, from knockout and knock-in cell models to library screening and bioinformatics.
References
- 1. Bell I et al.. 2024. Nkd1 functions downstream of Axin2 to attenuate Wnt signaling.. Mol Biol Cell 35(7):ar93 PMID: 38656801
- 2. Kim IM et al.. 2016. Vitamin D and Cardiac Differentiation.. Vitam Horm 100:299-320 PMID: 26827957
- 3. Chi F et al.. 2023. MiR-30b-5p promotes myocardial cell apoptosis in rats with myocardial infarction through regulating Wnt/β-catenin signaling pathway.. Minerva Med 114(4):476-484 PMID: 32255311
- 4. Cheng WL et al.. 2017. Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice.. J Am Heart Assoc 6(2) PMID: 28219919
- 6. Song G et al.. 2018. Deletion of Pr72 causes cardiac developmental defects in Zebrafish.. PLoS One 13(11):e0206883 PMID: 30481179
- 7. Di Sante M et al.. 2023. Monoamine oxidase A-dependent ROS formation modulates human cardiomyocyte differentiation through AKT and WNT activation.. Basic Res Cardiol 118(1):4 PMID: 36670288
- 8. Benz F et al.. 2019. Low wnt/β-catenin signaling determines leaky vessels in the subfornical organ and affects water homeostasis in mice.. Elife 8 PMID: 30932814
